A Phase Ib, Open-Label Study of Dalantercept, an Activin Receptor-Like Kinase 1 Ligand Trap, plus Sorafenib in Advanced Hepatocellular Carcinoma Article

Industry Collaboration

cited authors

  • Abou-Alfa, Ghassan K.; Miksad, Rebecca A.; Tejani, Mohamedtaki A.; Williamson, Stephen; Gutierrez, Martin E.; Olowokure, Olugbenga O.; Sharma, Manish R.; El Dika, Imane; Sherman, Matthew L.; Pandya, Shuchi S.

authors

Publication Date

  • February 1, 2019

webpage

published in

category

start page

  • 161

end page

  • +

volume

  • 24

issue

  • 2